Simplifying & Standarizing Aortic Valve Repair

HAART Aortic Valve Repair Technologies

Resize the aortic valve annulus to reduce dilatation

Reshape the aortic valve to restore more normal, three-dimensional coaptation geometry

Stabilize the aortic valve to reduce the risk of recurrent annular dilatation

Comprehensive Aortic Valve Repair Solution

Used with Isolated AI, Aneurysms with AI, Dissections with AI, Bicuspid Aortic Valve, and more …

See all applications

Rapidly Expanding Clinical Evidence & Experience

36
Peer Reviewed Publications

Clinical Evidence

125
Trained Surgeons

Find a Surgeon

87
Trained Centers

Find a Center

Valve Sparing Root
Replacement Simplified

Restores & Stablizes the Annulus
without Root Mobilization

Learn More
Get Started

BIOSTABLE Science & Engineering

Simplifying and Standardizing Aortic Valve Repair

Developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease.

Read more about our company, management and mission.

BioStable HAART Technologies products - Aortic Heart Valve Repair and Aortic Root Restoration

Get Started

HAART Technologies – Simplifying & Standarizing Aortic Valve Repair

Surgeon Training

Case Review

Sales Representative

Press Release

Press Release — Austin, TX – August 6, 2020 — BioStable Science & Engineering Initiates European Commercialization of the HAART™ 200 Aortic Annuloplasty Device

First commercial implantations of the HAART 200 Device for Bicuspid Aortic Valve repair performed by Professor Marek Jasinski at the Wroclaw Medical University … [Read more]

Press Release — Austin, TX – April 21, 2021 — CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices

The company has received CE Mark approval for the HAART 200 Aortic Annuloplasty Device for use during bicuspid aortic valve [Read more]

Press Release — Austin, TX – Feb 25, 2020 — BioStable Science & Engineering Announces Initial Closing of Series C Equity Round

Lead investors Rex Health Ventures and Orlando Health Ventures were joined by Longmeadow Health Care Partners, Santé Health Ventures, Solas BioVentures, and other prior investors … [Read more]